Annual Accounts Receivable
$173.00 K
-$97.00 K-35.93%
October 1, 2024
Summary
- As of February 8, 2025, ANIX annual accounts receivable is $173.00 thousand, with the most recent change of -$97.00 thousand (-35.93%) on October 1, 2024.
- ANIX annual accounts receivable is now -67.75% below its all-time high of $536.40 thousand, reached on October 31, 2001.
Performance
ANIX Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$173.00 K
-$237.00 K-57.80%
October 1, 2024
Summary
- As of February 8, 2025, ANIX quarterly accounts receivable is $173.00 thousand, with the most recent change of -$237.00 thousand (-57.80%) on October 1, 2024.
- Over the past year, ANIX quarterly accounts receivable has dropped by -$97.00 thousand (-35.93%).
- ANIX quarterly accounts receivable is now -79.12% below its all-time high of $828.40 thousand, reached on April 30, 2014.
Performance
ANIX Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
ANIX Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -35.9% | -35.9% |
| 3 y3 years | - | -48.2% |
| 5 y5 years | +160.2% | -48.2% |
ANIX Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -35.9% | +276.1% | -57.8% | +276.1% |
| 5 y | 5-year | -35.9% | +276.1% | -57.8% | +2783.3% |
| alltime | all time | -67.8% | -100.0% | -79.1% | -100.0% |
Anixa Biosciences Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Oct 2024 | $173.00 K(-35.9%) | $173.00 K(-57.8%) |
| Jul 2024 | - | $410.00 K(+88.1%) |
| Apr 2024 | - | $218.00 K(-44.2%) |
| Jan 2024 | - | $391.00 K(+44.8%) |
| Oct 2023 | $270.00 K(+487.0%) | $270.00 K(-19.2%) |
| Jul 2023 | - | $334.00 K(+30.5%) |
| Apr 2023 | - | $256.00 K(+74.1%) |
| Jan 2023 | - | $147.00 K(+219.6%) |
| Oct 2022 | $46.00 K(-30.8%) | $46.00 K(+666.7%) |
| Jul 2020 | - | $6000.00(-81.4%) |
| Apr 2020 | - | $32.30 K(+44.8%) |
| Jan 2020 | - | $22.30 K(-66.5%) |
| Oct 2019 | $66.50 K(-78.3%) | $66.50 K(+5945.5%) |
| Jul 2019 | - | $1100.00(-99.9%) |
| Apr 2019 | - | $797.00 K(+159.6%) |
| Oct 2018 | $307.00 K(-23.3%) | $307.00 K(+38.9%) |
| Jul 2017 | - | $221.00 K(>+9900.0%) |
| Jul 2015 | - | $0.00(0.0%) |
| Apr 2015 | - | $0.00(-100.0%) |
| Jan 2015 | - | $45.00 K(-88.8%) |
| Oct 2014 | $400.00 K(+128.6%) | $400.00 K(+200.1%) |
| Jul 2014 | - | $133.30 K(-83.9%) |
| Apr 2014 | - | $828.40 K(>+9900.0%) |
| Jan 2014 | - | $0.00(-100.0%) |
| Oct 2013 | $175.00 K(>+9900.0%) | $175.00 K(>+9900.0%) |
| Oct 2012 | $0.00 | $0.00(-100.0%) |
| Jul 2010 | - | $4500.00(-41.6%) |
| Apr 2010 | - | $7700.00(>+9900.0%) |
| Jan 2010 | - | $0.00(-100.0%) |
| Jul 2009 | - | $12.10 K(-88.6%) |
| Apr 2009 | - | $106.00 K(-5.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jan 2009 | - | $111.80 K(+8.5%) |
| Oct 2008 | $103.00 K(-14.2%) | $103.00 K(-50.3%) |
| Jul 2008 | - | $207.40 K(+8.9%) |
| Apr 2008 | - | $190.50 K(+217.5%) |
| Jan 2008 | - | $60.00 K(-50.0%) |
| Oct 2007 | $120.00 K(+1076.5%) | $120.00 K(+100.0%) |
| Jul 2007 | - | $60.00 K(0.0%) |
| Apr 2007 | - | $60.00 K(-12.8%) |
| Jan 2007 | - | $68.80 K(+574.5%) |
| Oct 2006 | $10.20 K(-68.2%) | $10.20 K(-47.7%) |
| Jul 2006 | - | $19.50 K(-61.2%) |
| Apr 2006 | - | $50.20 K(>+9900.0%) |
| Jan 2006 | - | $300.00(-99.1%) |
| Oct 2005 | $32.10 K(-49.4%) | $32.10 K(-66.3%) |
| Jul 2005 | - | $95.30 K(+349.5%) |
| Apr 2005 | - | $21.20 K(-89.6%) |
| Jan 2005 | - | $204.10 K(+221.4%) |
| Oct 2004 | $63.50 K(+53.0%) | $63.50 K(-2.8%) |
| Jul 2004 | - | $65.30 K(+46.1%) |
| Apr 2004 | - | $44.70 K(+246.5%) |
| Jan 2004 | - | $12.90 K(-68.9%) |
| Oct 2003 | $41.50 K(-46.7%) | $41.50 K(+13.7%) |
| Jul 2003 | - | $36.50 K(-50.6%) |
| Apr 2003 | - | $73.90 K(-47.2%) |
| Jan 2003 | - | $140.00 K(+79.9%) |
| Oct 2002 | $77.80 K(-85.5%) | $77.80 K(-61.5%) |
| Jul 2002 | - | $201.90 K(-60.2%) |
| Apr 2002 | - | $507.50 K(-9.8%) |
| Jan 2002 | - | $562.50 K(+4.9%) |
| Oct 2001 | $536.40 K | $536.40 K(-22.8%) |
| Jul 2001 | - | $694.40 K(-1.9%) |
| Apr 2001 | - | $707.90 K |
FAQ
- What is Anixa Biosciences annual accounts receivable?
- What is the all time high annual accounts receivable for Anixa Biosciences?
- What is Anixa Biosciences annual accounts receivable year-on-year change?
- What is Anixa Biosciences quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Anixa Biosciences?
- What is Anixa Biosciences quarterly accounts receivable year-on-year change?
What is Anixa Biosciences annual accounts receivable?
The current annual accounts receivable of ANIX is $173.00 K
What is the all time high annual accounts receivable for Anixa Biosciences?
Anixa Biosciences all-time high annual accounts receivable is $536.40 K
What is Anixa Biosciences annual accounts receivable year-on-year change?
Over the past year, ANIX annual accounts receivable has changed by -$97.00 K (-35.93%)
What is Anixa Biosciences quarterly accounts receivable?
The current quarterly accounts receivable of ANIX is $173.00 K
What is the all time high quarterly accounts receivable for Anixa Biosciences?
Anixa Biosciences all-time high quarterly accounts receivable is $828.40 K
What is Anixa Biosciences quarterly accounts receivable year-on-year change?
Over the past year, ANIX quarterly accounts receivable has changed by -$97.00 K (-35.93%)